Health
Olfactory and gustatory impairments in COVID‐19 patients: Role in early diagnosis and interferences by concomitant drugs – Ferraro – – British Journal of Clinical Pharmacology – Wiley Online Library – Wiley
Click on the article title to read more.
The COVID19 pandemic spread worldwide with over 38 million confirmed cases and more than 1 million deaths as of October 15, 2020. The clinical manifestations of SARSCoV2 infection range from asymptomatic to lifethreatening pneumonia, with the main symptoms being respiratory and gastrointestinal in nature. However, several patients report neurological symptoms including smell and taste impairments, such as anosmia, cacosmia, ageusia and dysgeusia.1 Although the spread of the disease has been favoured…
-
General17 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business17 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General19 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General20 hours agoAlbanese beats drum on economy as trade clouds gather